{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-014689","form_type":"8-K","ticker":"INDP","cik":"0001857044","company_name":"Indaptus Therapeutics, Inc.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:50.200811+00:00","generated_at":"2026-05-19T14:01:52.240151+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Indaptus Therapeutics shareholders approve reverse stock split authorization at annual meeting","bullets":["Elected Class I directors: Gilbert, Karah, Martell; each received ~3.4M votes for.","Ratified Haskell & White LLP as independent auditor for FY2025 (7,416,332 for).","Advisory say-on-pay approved: 3,346,942 for, 768,207 against.","Reverse stock split amendment approved (6,777,054 for); ratio 1:5 to 1:28, board discretion.","Approximately 52% of outstanding shares (8,386,348) were represented at the meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-014689","json":"https://secwatch.observer/filing/0001641172-25-014689.json","markdown":"https://secwatch.observer/filing/0001641172-25-014689.md","text":"https://secwatch.observer/filing/0001641172-25-014689.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225014689/0001641172-25-014689-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1857044/000164117225014689/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T14:01:52.240151+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}